68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke "GRGDS"


Phase Early 1 Results N/A

Summary of Purpose

This is an open-label brain PET/CT (positron emission tomography/computed tomography) study to investigate the diagnostic performance of 68Ga-BNOTA-PRGD2 in evaluation of stroke patients in convalescence. A single dose of nearly 111 MBq 68Ga-BNOTA-PRGD2 ( ≤ 40 µg BNOTA-PRGD2) will be intravenously injected into the patients. Visual and semi-quantitative method will be used to assess the PET/CT images. Changes of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 April 2017.

1 Feb 2012 1 Aug 2012 1 Dec 2017 1 Dec 2017 1 Nov 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Masking: Open Label
  • Purpose: Diagnostic
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment